New on this website

16.10.2018

Out-of-Stock – Natulan, Hartkapseln

Befristete Bewilligung zum Vertrieb in internationaler Aufmachung

11.10.2018

Batch recall – Xenetix 350, Injektionslösung

Rückruf der Charge 18WF044C01 bis auf Stufe Detailhandel

03.10.2018

Batch recall – Ozurdex, intravitreales Implantat in Applikator

Zusatzinformation zum Chargenrückruf vom 07.09.2018

03.10.2018

Swissmedic Journal

Latest edition
Swissmedic Journal September 2018

01.10.2018

Valsartan: Extended investigations – products on Swiss market tested to date give no cause for concern

Like the previously analysed products with valsartan, products with losartan, olmesartan and candesartan that have been investigated do not contain elevated NDMA levels.

30.09.2018

Procedure for submitting applications according to HMV4 before 1 January 2019

As of 1 December 2018 Swissmedic will accept submissions with the documents updated according to HMV4.

30.09.2018

Revision of the Therapeutic Products Act (TPA): Publication of the specification documents and forms for authorisation applications

Owing to the revision of the TPA and the corresponding implementing ordinances (Therapeutic Products Ordinance Package IV), Swissmedic has adapted the specification documents and forms for authorisation applications.

30.09.2018

Updating of various specification documents connected with HMV4

Various eDok and eCTD specification documents are being updated

28.09.2018

ICT - Systemadministrator/in 80 %

Stellenausschreibung | Abteilung Arzneimittelsicherheit

27.09.2018

Out-of-Stock – HBVAXPRO 40, Injektionssuspension

Befristete Bewilligung zum Vertrieb in holländischer Aufmachung.

Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page

Last modification 08.10.2018

Top of page